Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15920900rdf:typepubmed:Citationlld:pubmed
pubmed-article:15920900lifeskim:mentionsumls-concept:C0038410lld:lifeskim
pubmed-article:15920900lifeskim:mentionsumls-concept:C0055856lld:lifeskim
pubmed-article:15920900lifeskim:mentionsumls-concept:C0036576lld:lifeskim
pubmed-article:15920900lifeskim:mentionsumls-concept:C0370215lld:lifeskim
pubmed-article:15920900lifeskim:mentionsumls-concept:C0683598lld:lifeskim
pubmed-article:15920900lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:15920900lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:15920900pubmed:issue2lld:pubmed
pubmed-article:15920900pubmed:dateCreated2005-5-30lld:pubmed
pubmed-article:15920900pubmed:abstractTextIn this study the effects of exposure to serum, lung and breakpoint concentrations on Streptococcus pneumoniae susceptibility to clarithromycin, azithromycin, amoxicillin/clavulanate, levofloxacin and moxifloxacin were evaluated. Development of resistance was determined by multi-step and single-step methodologies. In the first experimental set, minimum inhibitory concentrations (MICs) were determined after 10 passages on antibiotic-gradient plates and 10 passages on antibiotic-free plates. Acquisition of resistance was defined as an increase of > or = 4-fold from the starting MIC. In single-step studies, the rate of spontaneous mutations was calculated after a passage on antibiotic-containing agar plates. Azithromycin and levofloxacin gave the highest number of strains with MIC increased of at least 4 times the starting value, followed by moxifloxacin and by clarithromycin which only at the lowest concentration tested selected for resistance in 5 strains. Amoxicillin/clavulanate never displayed > or = 4-fold MIC increase. Frequencies of mutation were lower for clarithromycin and moxifloxacin than for the comparators. At lung concentrations clarithromycin had limited potential to select for resistance.lld:pubmed
pubmed-article:15920900pubmed:languageenglld:pubmed
pubmed-article:15920900pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15920900pubmed:citationSubsetIMlld:pubmed
pubmed-article:15920900pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15920900pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15920900pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15920900pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15920900pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15920900pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15920900pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15920900pubmed:statusMEDLINElld:pubmed
pubmed-article:15920900pubmed:monthAprlld:pubmed
pubmed-article:15920900pubmed:issn1120-009Xlld:pubmed
pubmed-article:15920900pubmed:authorpubmed-author:RipaSSlld:pubmed
pubmed-article:15920900pubmed:authorpubmed-author:PrennaMMlld:pubmed
pubmed-article:15920900pubmed:authorpubmed-author:LegnaniDDlld:pubmed
pubmed-article:15920900pubmed:authorpubmed-author:DragoLLlld:pubmed
pubmed-article:15920900pubmed:authorpubmed-author:De VecchiEElld:pubmed
pubmed-article:15920900pubmed:authorpubmed-author:NicolaLLlld:pubmed
pubmed-article:15920900pubmed:issnTypePrintlld:pubmed
pubmed-article:15920900pubmed:volume17lld:pubmed
pubmed-article:15920900pubmed:ownerNLMlld:pubmed
pubmed-article:15920900pubmed:authorsCompleteYlld:pubmed
pubmed-article:15920900pubmed:pagination161-8lld:pubmed
pubmed-article:15920900pubmed:dateRevised2009-8-4lld:pubmed
pubmed-article:15920900pubmed:meshHeadingpubmed-meshheading:15920900...lld:pubmed
pubmed-article:15920900pubmed:meshHeadingpubmed-meshheading:15920900...lld:pubmed
pubmed-article:15920900pubmed:meshHeadingpubmed-meshheading:15920900...lld:pubmed
pubmed-article:15920900pubmed:meshHeadingpubmed-meshheading:15920900...lld:pubmed
pubmed-article:15920900pubmed:meshHeadingpubmed-meshheading:15920900...lld:pubmed
pubmed-article:15920900pubmed:meshHeadingpubmed-meshheading:15920900...lld:pubmed
pubmed-article:15920900pubmed:meshHeadingpubmed-meshheading:15920900...lld:pubmed
pubmed-article:15920900pubmed:meshHeadingpubmed-meshheading:15920900...lld:pubmed
pubmed-article:15920900pubmed:meshHeadingpubmed-meshheading:15920900...lld:pubmed
pubmed-article:15920900pubmed:meshHeadingpubmed-meshheading:15920900...lld:pubmed
pubmed-article:15920900pubmed:meshHeadingpubmed-meshheading:15920900...lld:pubmed
pubmed-article:15920900pubmed:meshHeadingpubmed-meshheading:15920900...lld:pubmed
pubmed-article:15920900pubmed:year2005lld:pubmed
pubmed-article:15920900pubmed:articleTitleIn vitro selection of resistance to clarithromycin in Streptococcus pneumoniae clinical isolates.lld:pubmed
pubmed-article:15920900pubmed:affiliationLaboratory of Clinical Microbiology, Dept of Clinical Sciences, L. Sacco Teaching Hospital, University of Milan. lorenzo.drago@unimi.itlld:pubmed
pubmed-article:15920900pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15920900pubmed:publicationTypeComparative Studylld:pubmed